Signed in
We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.
Welcome to Pump.fun!
Pump lets anyone create coins, giving everyone equal access to buy and sell from the start. Prices can move quickly, so trade carefully.
By clicking this button, you agree to the Terms and Conditions, Privacy Policy, and certify that you are over 18 years old.
We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.
Reviva Pharmaceuticals Holdings, Inc. (RVPH) is a late-stage biopharma innovator targeting unmet needs in CNS, respiratory, inflammatory, and cardiometabolic disorders. Flagship candidate brilaroxazine (RP5063) advances Phase 3 trials for schizophrenia and bipolar disorder, with potential in ADHD, dementia psychosis, and pulmonary hypertension. Pipeline includes RP1208 for depression/obesity. Founded 2018, HQ in Cupertino, CA. Recent catalysts: 93% monthly stock surge amid trial momentum. High-risk/high-reward biotech play—monitor FDA milestones for explosive upside.